Impact of the diagnosis of metabolic dysfunction-associated fatty liver disease and non-alcoholic fatty liver disease in patients undergoing liver transplantation for hepatocellular carcinoma
PurposeWhether the diagnosis of non-alcoholic fatty liver disease or metabolic dysfunction-associated fatty disease has a different impact on liver transplant recipients with hepatocellular carcinoma is not yet clear.MethodsData from a two-center retrospective cohort study were collected to compare...
Guardado en:
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Frontiers Media S.A.
2024-04-01
|
| Colección: | Frontiers in Endocrinology |
| Materias: | |
| Acceso en línea: | https://www.frontiersin.org/articles/10.3389/fendo.2024.1306091/full |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
